XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: LarryS who wrote (7266)	9/22/1998 10:00:00 AM
From: aknahow	Read Replies (1) of 17367

Not sure I understand it either. However, I do see how the review could be a big plus if it ends up with a recommendation for an "early" halt. In that case it seems there would be the time savings due to being able to go to the FDA with the data already in hand rather than waiting an additional 90 days after the last patient would have been enrolled with a normal trial termination. I do not understand at all how at this late date the "trial" itself would be changed. not saying it can't, but just that I don't understand at all how one could or would change it at such a late date. Do see they could say get 20 more patients, but even in this case not sure how 20 more on top of say 290 (???) would make a statistical difference.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next